Japan
· Delayed Price · Currency is JPY Riken Vitamin Statistics
Total Valuation
Riken Vitamin has a market cap or net worth of JPY 76.15 billion. The enterprise value is 63.80 billion.
| Market Cap | 76.15B |
| Enterprise Value | 63.80B |
Important Dates
The last earnings date was Wednesday, May 14, 2025.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | Mar 28, 2025 |
Share Statistics
Riken Vitamin has 29.87 million shares outstanding. The number of shares has decreased by -7.17% in one year.
| Current Share Class | 29.87M |
| Shares Outstanding | 29.87M |
| Shares Change (YoY) | -7.17% |
| Shares Change (QoQ) | -1.07% |
| Owned by Insiders (%) | 11.06% |
| Owned by Institutions (%) | 26.91% |
| Float | 20.03M |
Valuation Ratios
The trailing PE ratio is 8.22.
| PE Ratio | 8.22 |
| Forward PE | n/a |
| PS Ratio | 0.80 |
| PB Ratio | 0.96 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | 23.69 |
| P/OCF Ratio | 9.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.35, with an EV/FCF ratio of 19.85.
| EV / Earnings | 6.80 |
| EV / Sales | 0.67 |
| EV / EBITDA | 5.35 |
| EV / EBIT | 7.31 |
| EV / FCF | 19.85 |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.13.
| Current Ratio | 3.11 |
| Quick Ratio | 2.09 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.83 |
| Debt / FCF | 3.08 |
| Interest Coverage | 70.93 |
Financial Efficiency
Return on equity (ROE) is 12.05% and return on invested capital (ROIC) is 6.00%.
| Return on Equity (ROE) | 12.05% |
| Return on Assets (ROA) | 4.71% |
| Return on Invested Capital (ROIC) | 6.00% |
| Return on Capital Employed (ROCE) | 9.50% |
| Revenue Per Employee | 51.47M |
| Profits Per Employee | 5.06M |
| Employee Count | 1,857 |
| Asset Turnover | 0.82 |
| Inventory Turnover | 3.37 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.35% in the last 52 weeks. The beta is -0.09, so Riken Vitamin's price volatility has been lower than the market average.
| Beta (5Y) | -0.09 |
| 52-Week Price Change | -0.35% |
| 50-Day Moving Average | 2,484.86 |
| 200-Day Moving Average | 2,505.71 |
| Relative Strength Index (RSI) | 55.24 |
| Average Volume (20 Days) | 50,625 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Riken Vitamin had revenue of JPY 95.58 billion and earned 9.39 billion in profits. Earnings per share was 310.06.
| Revenue | 95.58B |
| Gross Profit | 31.27B |
| Operating Income | 8.73B |
| Pretax Income | 12.70B |
| Net Income | 9.39B |
| EBITDA | 11.93B |
| EBIT | 8.73B |
| Earnings Per Share (EPS) | 310.06 |
Balance Sheet
The company has 22.30 billion in cash and 9.91 billion in debt, giving a net cash position of 12.38 billion or 414.55 per share.
| Cash & Cash Equivalents | 22.30B |
| Total Debt | 9.91B |
| Net Cash | 12.38B |
| Net Cash Per Share | 414.55 |
| Equity (Book Value) | 79.20B |
| Book Value Per Share | 2,649.84 |
| Working Capital | 44.57B |
Cash Flow
In the last 12 months, operating cash flow was 7.89 billion and capital expenditures -4.68 billion, giving a free cash flow of 3.21 billion.
| Operating Cash Flow | 7.89B |
| Capital Expenditures | -4.68B |
| Free Cash Flow | 3.21B |
| FCF Per Share | 107.59 |
Margins
Gross margin is 32.72%, with operating and profit margins of 9.13% and 9.82%.
| Gross Margin | 32.72% |
| Operating Margin | 9.13% |
| Pretax Margin | 13.29% |
| Profit Margin | 9.82% |
| EBITDA Margin | 12.48% |
| EBIT Margin | 9.13% |
| FCF Margin | 3.36% |
Dividends & Yields
This stock pays an annual dividend of 110.00, which amounts to a dividend yield of 4.34%.
| Dividend Per Share | 110.00 |
| Dividend Yield | 4.34% |
| Dividend Growth (YoY) | 16.05% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 29.57% |
| Buyback Yield | 7.17% |
| Shareholder Yield | 11.51% |
| Earnings Yield | 12.33% |
| FCF Yield | 4.22% |
Stock Splits
The last stock split was on March 30, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Mar 30, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
Riken Vitamin has an Altman Z-Score of 3.76.
| Altman Z-Score | 3.76 |
| Piotroski F-Score | n/a |